FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CDT Nasdaq CDT Equity Inc. 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEN Nasdaq Compugen Ltd. 2830
CLDI NYSE American Calidi Biotherapeutics, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLNN Nasdaq Clene Inc. 2830
CLRB Nasdaq Cellectar Biosciences, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNTA Nasdaq Centessa Pharmaceuticals plc 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
COEP Nasdaq Coeptis Therapeutics Holdings, Inc. 2830
COGT Nasdaq Cogent Biosciences, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPRX Nasdaq Catalyst Pharmaceuticals, Inc. 2830
CRBP Nasdaq Corbus Pharmaceuticals Holdings, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRDL Nasdaq Cardiol Therapeutics Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CSLLY Over the counter CSL Limited 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CUPR Nasdaq Cuprina Holdings (Cayman) Limited 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CVKD Nasdaq Cadrenal Therapeutics, Inc. 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DERM Nasdaq Journey Medical Corporation 2830
DFTX Nasdaq Definium Therapeutics, Inc. 2830
DSNKY Over the counter Daiichi Sankyo Company, Limited 2830
DVAX Nasdaq Dynavax Technologies Corporation 2830
DYAI Nasdaq Dyadic International, Inc. 2830
EBS New York Emergent BioSolutions Inc. 2830
EDIT Nasdaq Editas Medicine, Inc. 2830
EDSA Nasdaq Edesa Biotech, Inc. 2830
ENLV Nasdaq Enlivex Therapeutics Ltd. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
ETON Nasdaq Eton Pharmaceuticals, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
EVO Nasdaq Evotec SE 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
EYPT Nasdaq EyePoint, Inc. 2830
FHTX Nasdaq Foghorn Therapeutics Inc. 2830
FOLD Nasdaq Amicus Therapeutics, Inc. 2830
FTRE Nasdaq Fortrea Holdings Inc. 2830
GALDY Over the counter Galderma Group AG 2830
Results 50 through 100 of 277